Morgan Stanley’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-37,296
| Closed | -$9.51K | – | 7818 |
|
|
2023
Q1 | $9.51K | Sell |
37,296
-16,264
| -30% | -$4.15K | ﹤0.01% | 6902 |
|
|
2022
Q4 | $63.2K | Buy |
53,560
+29,326
| +121% | +$34.6K | ﹤0.01% | 6187 |
|
|
2022
Q3 | $49K | Buy |
24,234
+22,013
| +991% | +$44.5K | ﹤0.01% | 6419 |
|
|
2022
Q2 | $3K | Sell |
2,221
-3,420
| -61% | -$4.62K | ﹤0.01% | 7551 |
|
|
2022
Q1 | $29K | Buy |
5,641
+3,219
| +133% | +$16.5K | ﹤0.01% | 6984 |
|
|
2021
Q4 | $15K | Buy |
2,422
+2,102
| +657% | +$13K | ﹤0.01% | 7333 |
|
|
2021
Q3 | $3K | Buy |
+320
| New | +$3K | ﹤0.01% | 7622 |
|